(Q36419551)

14 August 2017

1 reference

title

When migraine progresses: transformed or chronic migraine (English)

1 reference

14 August 2017

1 reference

1

Marcelo E Bigal

1 reference

14 August 2017

2

Richard B Lipton

1 reference

14 August 2017

1 March 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

3

1 reference

14 August 2017

297-306

1 reference

Is migraine a progressive brain disease?

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Classification and epidemiology of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Transformed or evolutive migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Prevalence of frequent headache in a population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Migraine days decline with duration of illness in adolescents with transformed migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Primary chronic daily headache and its subtypes in adolescents and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Factors associated with the onset and remission of chronic daily headache in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Habitual snoring as a risk factor for chronic daily headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Obesity and migraine: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is a cause of chronic daily headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Withdrawal syndrome after the double-blind cessation of caffeine consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Opiate use to control bowel motility may induce chronic daily headache in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Does chronic daily headache arise de novo in association with regular use of analgesics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Headache induced by chronic substance use: analysis of medication overused and minimum dose required to induce headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Subcutaneous Sumatriptan in the Treatment of Headache During Withdrawal From Drug-Induced Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Daily sumatriptan for detoxification from rebound

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Repetitive intravenous dihydroergotamine as therapy for intractable migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Double-blind trial of fluoxetine: chronic daily headache and migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

Nefazodone for chronic daily headache prophylaxis: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.3.297

21 January 2018

Identifiers

DOI

10.1586/14737175.6.3.297

1 reference

release_dt44yw3r75a5bkjhsuimddxwwq

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dt44yw3r75a5bkjhsuimddxwwq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16533134

1 reference

PubMed ID

16533134